Description
GLOW is a laboratory-formulated research peptide blend supplied by AusPepLabs, combining three extensively studied research compounds — TB-500 (Thymosin Beta-4), BPC-157, and GHK-Cu (Copper Tripeptide-1) – in a single 70mg lyophilized vial. Each component targets distinct molecular pathways, making GLOW a useful multi-pathway research tool for laboratories investigating cytoskeletal biology, gastrointestinal peptide signaling, and copper-dependent cellular modeling within a single experimental system. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For scientific research use only.
Why Research Laboratories Select GLOW
GLOW combines three mechanistically distinct research peptides in a single convenient vial, enabling laboratories to investigate multiple signaling pathways simultaneously. TB-500 acts on cytoskeletal actin dynamics via the LKKTETQ active site. BPC-157 interacts with nitric oxide and VEGF signaling pathways. GHK-Cu modulates copper-dependent enzymatic activity and extracellular matrix signaling. Together they provide a multi-pathway reference system relevant to tissue biology and cellular remodeling research.
- Three-component blend – TB-500, BPC-157, and GHK-Cu in one 70mg lyophilized vial
- Multi-pathway research system – cytoskeletal, gastrointestinal peptide, and copper-dependent signaling studied simultaneously
- GHK-Cu at 50mg dominant concentration – suited for extracellular matrix and copper-peptide complex research
- TB-500 and BPC-157 at 10mg each -complementary tissue biology research concentrations
- Each component independently verified to ≥99% HPLC purity
- Lyophilized format ensures stability and reproducibility across experimental runs
Component Overview
| TB-500 (10mg) | (CAS 77591-33-4.) 43 amino acid synthetic peptide corresponding to Thymosin Beta-4. Studied for actin-binding properties, G-actin sequestration, and cytoskeletal remodeling in preclinical research models. |
| BPC-157 (10mg) | (CAS 137525-51-0.) 15 amino acid synthetic pentadecapeptide derived from human gastric juice protein. Studied for nitric oxide pathway interactions and angiogenic signaling in preclinical research models. |
| GHK-Cu (50mg) | (CAS 49557-75-7). Naturally occurring copper-binding tripeptide (Gly-His-Lys·Cu²⁺). Studied for extracellular matrix signaling, copper-dependent enzymatic activity, and gene expression modulation in cellular research models. |

Reviews
There are no reviews yet.